SCHEMBL1957647

SCHEMBL1957647

CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N(C5CCNCC5)C5CCOCC5)c([N+](=O)[O-])c4)c(OCc4csc(N)n4)c3)CC2)=C(c2ccc(Cl)cc2)C1

nearest known ligand 0.76

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 18/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1958625 0.91 BCL2 (0.64) BCL2
SCHEMBL1959229 0.86 BCL2 (1.00) BCL2
SCHEMBL1959370 0.85 BCL2 (0.65) BCL2
SCHEMBL1957224 0.85 BCL2 (1.00) BCL2
SCHEMBL1957452 0.85 BCL2 (0.75) BCL2
SCHEMBL1957954 0.84 BCL2 (0.71) BCL2
SCHEMBL2481108 0.84 BCL2 (0.79) BCL2
SCHEMBL1959100 0.83 BCL2 (0.66) BCL2
SCHEMBL2481508 0.81 BCL2 (0.73) BCL2
SCHEMBL2480390 0.80 BCL2 (0.75) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2507211-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2012-10-10 — — EP disclosed
WO-2011068560-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-06-09 — — WO disclosed
Send feedback